(NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on June 16, ...

“FibroGen has differentiated potential first-in-class assets and the company is positioning itself for a significant turnaround over the next several years,” said Dr. Kauffman.“It is an honor to join ...

This program also includes the development of FG-3180, an associated CD46-targeted PET biomarker. For more information, please visit www.fibrogen.com. The articles, information, and content ...

FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and ...

This program also includes the development of FG-3180, an associated CD46-targeted PET biomarker. For more information, please visit www.fibrogen.com. The articles, information, and content ...

But it doesn’t merely eat these pieces for food; it steals their proteins, namely CD46 and CD55, from the outer membrane of the cell and cloaks them around its own surface. These two proteins ...

FibroGen does have various earlier-stage projects in the pipeline, headed by FG-3246, a CD46-targeting antibody-drug conjugate (ADC) for the treatment of metastatic castration-resistant prostate ...

Amoebas don’t usually make headlines. But Entamoeba histolytica, a single-celled killer with a taste for human cells, may deserve the spotlight. This microscopic parasite infects up to 50 million ...